Skip to content

Medical-device intelligence

QJR: Reagents, 2019-Novel Coronavirus Nucleic Acid

FDA product code QJR: Reagents, 2019-Novel Coronavirus Nucleic Acid. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QJR
FDA device name
Reagents, 2019-Novel Coronavirus Nucleic Acid
Device class
N
Regulation number
Not provided
Medical specialty
Unknown
Review panel
MI

FDA definition

Nucleic acid-based in vitro diagnostic devices for the detection of 2019-novel coronavirus (2019-nCoV) and/or diagnosis of 2019-nCoV infection in human clinical specimens.
Explore unknown records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

0 clearance records and 40 recall records in the covered releases, across 16 source company names and 1 product codes. Dated history runs from Jul 20, 2020 to Apr 28, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
QJR · Reagents, 2019-Novel Coronavirus Nucleic Acid040

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

40 matching records
Device / recordCompany in FDA recordSourceSource date
Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a multiplex real-time reverse transcription (RT) polymerase chain reac…Z-1748-2025 · QJRAbbott Molecular, Inc.RecallMay 12, 2025FDA classification date
Alinity m Resp-4-Plex AMP Kit, List Number 09N79-096, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test inten…Z-1749-2025 · QJRAbbott Molecular, Inc.RecallMay 12, 2025FDA classification date
BD SARS-CoV-2 Reagents for BD MAX" Systems. RT-PCR test to detect SARS-CoV-2 in nasal, nasopharyngeal, oropharyngeal swab specimens, and saliva s…Z-2023-2024 · QJRBecton Dickinson & Co.RecallJun 5, 2024FDA classification date
QIAstat-Dx Respiratory SARS-CoV-2 Panel -IVD intended for the detection and differentiation of nucleic acid from SARS-CoV-2 and the following org…Z-2215-2023 · QJRQiagen GmbHRecallJul 21, 2023FDA classification date
NeuMoDx SARS-CoV-2 Assay -IVD intended for the qualitative detection of SARS-CoV-2 RNA from nasal, nasopharyngeal and oropharyngeal swabs in tra…Z-2093-2023 · QJRNeuMoDx Molecular IncRecallJul 5, 2023FDA classification date
Simplexa COVID-19 Direct, REF: MOL4150; including Reaction Mix, REF: MOL4150; with previous assay definition v2Z-1209-2023 · QJRDiaSorin Molecular LLCRecallMar 3, 2023FDA classification date
Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700Z-1008-2023 · QJRMeridian Bioscience IncRecallJan 20, 2023FDA classification date
Abbott Alinity m Resp-4-Plex Amp Kit, Part Number 09N79-096Z-0739-2023 · QJRAbbott Molecular, Inc.RecallDec 20, 2022FDA classification date
Abbott Alinity m Resp-4-Plex Amp Kit, Part Number 09N79-090Z-0740-2023 · QJRAbbott Molecular, Inc.RecallDec 20, 2022FDA classification date
CoViPoint COVID test kit (MultiPLEX/Direct) Kit Item Numbers: BC-DK0200; BM-AD4K0200 BM-ADK0200 BM-CDK0200 BM-CFDK0200 BM-D4K0200 BM-DK0200 BM-DK…Z-0324-2023 · QJRGS Biomark LLCRecallNov 29, 2022FDA classification date
ARIES SARS-CoV-2 Assay, REF: 50-10047Z-0134-2023 · QJRLuminex CorporationRecallOct 26, 2022FDA classification date
Abbott Alinity m SARS-CoV-2 CTRL Kit, REF 09N78-085, each kit contains 12 x 1.3mL CTRL - and 12 x 1.3 mL CTRL +, For In Vitro Diagnostic Use.Z-1679-2022 · QJRAbbott Molecular, Inc.RecallSep 6, 2022FDA record creation date
ARIES SARS-CoV-2 AssayZ-1524-2022 · QJRLuminex CorporationRecallAug 17, 2022FDA record creation date
Accula SARS-CoV-2 Test, REF: COV4100Z-1009-2022 · QJRMESA BIOTECH, INCRecallMay 6, 2022FDA record creation date
NeuMoDx Cartridge-For in vitro diagnostic use with NeuMoOx Molecular Systems with either of the following assays: NeuMoDx SARS CoV-2 Test Strip…Z-1000-2022 · QJRNeuMoDx Molecular IncRecallApr 22, 2022FDA record creation date
ORAcollect RNA: ORE-100Z-0982-2022 · QJRDNA Genotek Inc.RecallApr 21, 2022FDA record creation date
NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Ref # 300900 (marketed under EUA202947). Distributed in boxes of 6 assay strips in individual…Z-0738-2022 · QJRNeuMoDx Molecular IncRecallMar 8, 2022FDA record creation date
Biomeme SARS-CoV-2- Real Time RT-PCR Test, Instructions for Use, Part number 100002824 Subcomponent of: SARS-CoV-2 Go-Strips, 3000555; SARS-CoV-…Z-0452-2022 · QJRBiomeme, Inc.RecallJan 4, 2022FDA record creation date
SIMPLEXA COVID-19 Positive Control Pack, REF MOL4160, IVD, Rx Only, UDI: (01) 20816101027051Z-0162-2022 · QJRDiaSorin Molecular LLCRecallOct 21, 2021FDA record creation date
Alinity m SARS-CoV-2 Amp Kit (Emergency Use Authorization, US Assay) and Alinity m SARS-CoV-2 Application Specification File. in vitro diagnosti…Z-0004-2022 · QJRAbbott Molecular, Inc.RecallOct 14, 2021FDA classification date
Alinity m Resp-4-Plex AMP Kit (Emergency Use Authorization, US Assay) and Alinity m Resp-4-Plex Application Specification File. in vitro diagnost…Z-0005-2022 · QJRAbbott Molecular, Inc.RecallOct 14, 2021FDA classification date
Alinity m SARS-CoV-2 Amp Kit (Non-US Assay) and Alinity m SARS-CoV-2 Application Specification File. in vitro diagnosticZ-0006-2022 · QJRAbbott Molecular, Inc.RecallOct 14, 2021FDA classification date
Alinity m SARS-CoV-2 Amp Kit (Non-US Assay) and Alinity m SARS-CoV-2 Application Specification File. in vitro diagnosticZ-0007-2022 · QJRAbbott Molecular, Inc.RecallOct 14, 2021FDA classification date
Alinity m Resp-4-Plex AMP Kit (Non-US Assay) and Alinity m Resp-4-Plex Application Specification File. in vitro diagnosticZ-0008-2022 · QJRAbbott Molecular, Inc.RecallOct 14, 2021FDA classification date
Lyra Direct SARS-CoV-2 Assay Emergency Use Authorization- Ref: M124. The Lyra Direct SARS-CoV-2 Assay is a real-time RT-PCR assay intended for t…Z-2477-2021 · QJRQuidel CorporationRecallSep 15, 2021FDA record creation date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗